Marek Rusin

1.9k total citations
49 papers, 1.5k citations indexed

About

Marek Rusin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Marek Rusin has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 23 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Marek Rusin's work include Cancer-related Molecular Pathways (18 papers), DNA Repair Mechanisms (14 papers) and Epigenetics and DNA Methylation (7 papers). Marek Rusin is often cited by papers focused on Cancer-related Molecular Pathways (18 papers), DNA Repair Mechanisms (14 papers) and Epigenetics and DNA Methylation (7 papers). Marek Rusin collaborates with scholars based in Poland, United States and Australia. Marek Rusin's co-authors include Dorota Butkiewicz, Curtis C. Harris, Małgorzata Krześniak, Lindsey Enewold, Paula Shields, Monika Chorąży, Arkadiusz Samojedny, M Choraźy, Michael B. Yarmolinsky and Guy Plunkett and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Marek Rusin

47 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Rusin Poland 21 1.1k 416 366 254 193 49 1.5k
Robert S. Tebbs United States 12 1.3k 1.2× 413 1.0× 440 1.2× 176 0.7× 119 0.6× 24 1.5k
Heather E. Cunliffe New Zealand 16 932 0.8× 153 0.4× 146 0.4× 496 2.0× 105 0.5× 20 1.3k
Ling Yao China 23 883 0.8× 525 1.3× 231 0.6× 200 0.8× 72 0.4× 104 1.4k
Paula M. De Angelis Norway 17 512 0.5× 250 0.6× 438 1.2× 146 0.6× 245 1.3× 34 1.4k
Murali Dharan Bashyam India 20 761 0.7× 143 0.3× 261 0.7× 228 0.9× 87 0.5× 55 1.3k
Liang Zhu China 19 876 0.8× 181 0.4× 224 0.6× 147 0.6× 146 0.8× 47 1.4k
John F. DeCoteau Canada 24 903 0.8× 127 0.3× 401 1.1× 139 0.5× 372 1.9× 63 1.5k
E C Friedberg United States 19 2.1k 1.8× 406 1.0× 581 1.6× 309 1.2× 111 0.6× 35 2.3k
Alexandra Martins Portugal 23 1.2k 1.1× 149 0.4× 126 0.3× 474 1.9× 232 1.2× 74 1.8k
Ronit Aloni-Grinstein Israel 17 632 0.6× 180 0.4× 438 1.2× 146 0.6× 36 0.2× 33 964

Countries citing papers authored by Marek Rusin

Since Specialization
Citations

This map shows the geographic impact of Marek Rusin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Rusin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Rusin more than expected).

Fields of papers citing papers by Marek Rusin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Rusin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Rusin. The network helps show where Marek Rusin may publish in the future.

Co-authorship network of co-authors of Marek Rusin

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Rusin. A scholar is included among the top collaborators of Marek Rusin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Rusin. Marek Rusin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gdowicz‐Kłosok, Agnieszka, et al.. (2025). Antibacterial Activity of the p53 Tumor Suppressor Protein—How Strong Is the Evidence?. International Journal of Molecular Sciences. 26(9). 4416–4416.
2.
Rusin, Marek. (2024). The p53 protein – not only the guardian of the genome. Postępy Biochemii. 70(1). 71–87. 5 indexed citations
3.
Gdowicz‐Kłosok, Agnieszka, et al.. (2024). Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand. APOPTOSIS. 29(9-10). 1515–1528. 3 indexed citations
4.
Gdowicz‐Kłosok, Agnieszka, Beata Małachowska, Małgorzata Krześniak, et al.. (2024). Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes. Chemico-Biological Interactions. 392. 110946–110946. 3 indexed citations
5.
Czapla, Justyna, Sybilla Matuszczak, Tomasz Cichoń, et al.. (2023). Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context. Frontiers in Oncology. 13. 1249524–1249524. 11 indexed citations
6.
Rusin, Marek, et al.. (2023). The Wheel of p53 Helps to Drive the Immune System. International Journal of Molecular Sciences. 24(8). 7645–7645. 17 indexed citations
7.
Toma-Jonik, Agnieszka, Natalia Vydra, Piotr Wiland, et al.. (2020). Pro-death signaling of cytoprotective heat shock factor 1: upregulation of NOXA leading to apoptosis in heat-sensitive cells. Cell Death and Differentiation. 27(7). 2280–2292. 27 indexed citations
8.
Krześniak, Małgorzata, et al.. (2014). Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D. Mechanisms of Ageing and Development. 139. 11–21. 21 indexed citations
9.
Krześniak, Małgorzata, et al.. (2013). Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol. Molecular Biology Reports. 40(8). 5013–5026. 11 indexed citations
10.
Rusin, Marek, et al.. (2011). The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases. Mechanisms of Ageing and Development. 132(11-12). 543–551. 19 indexed citations
11.
Butkiewicz, Dorota, et al.. (2010). An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Molecular Biology Reports. 38(8). 5231–5241. 34 indexed citations
12.
Rusin, Marek, et al.. (2009). Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1. Mechanisms of Ageing and Development. 130(8). 528–537. 46 indexed citations
13.
Tysarowski, Andrzej, Anna Fabisiewicz, Jolanta Kupryjańczyk, et al.. (2008). Walidacja wybranych technik molekularnych oznaczania mutacji w kodonie 12 i 13 genu K-RAS przeprowadzona w pięciu ośrodkach badawczo-naukowych Polski. Jagiellonian University Repository (Jagiellonian University). 4(6). 232–244.
14.
Tysarowski, Andrzej, Anna Fabisiewicz, Jolanta Kupryjańczyk, et al.. (2008). Validation of selected molecular methods for the mutations determination in codons 12 and 13 of K-RAS gene in five Polish oncological research centers. Oncology in Clinical Practice. 4(6). 232–244. 1 indexed citations
15.
Butkiewicz, Dorota, Małgorzata Krześniak, Mirosław Śnietura, et al.. (2007). Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML. Mechanisms of Ageing and Development. 128(11-12). 650–661. 35 indexed citations
16.
Pamuła‐Piłat, Jolanta, Małgorzata Krześniak, Helena Zientek, et al.. (2006). Functional Impact of Sequence Alterations Found in BRCA1 Promoter/5'UTR Region in Breast/Ovarian Cancer Families from Upper Silesia, Poland. Hereditary Cancer in Clinical Practice. 4(1). 20–4. 5 indexed citations
17.
Pack, Svetlana, Özgül M. Alper, Kurt Stromberg, et al.. (2004). Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line. Cancer Research. 64(3). 789–794. 27 indexed citations
18.
Butkiewicz, Dorota, Marek Rusin, Curtis C. Harris, & M Choraźy. (2000). Identification of four single nucleotide polymorphisms in DNA repair genes:XPA andXPB(ERCC3) in Polish population. Human Mutation. 15(6). 577–578. 57 indexed citations
19.
Rusin, Marek, Arkadiusz Samojedny, Curtis C. Harris, & M Choraźy. (1999). Novel genetic polymorphisms in DNA repair genes: O6-methylguanine-DNA methyltransferase (MGMT) andN-methylpurine-DNA glycosylase (MPG) in lung cancer patients from Poland. Human Mutation. 14(3). 269–270. 24 indexed citations
20.
Burke, Louise, Khan Ma, Andrew N. Freedman, et al.. (1998). Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.. PubMed. 58(12). 2533–6. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert S. Tebbs Breakdown of academic impact, for papers by Heather E. Cunliffe Breakdown of academic impact, for papers by Ling Yao Breakdown of academic impact, for papers by Paula M. De Angelis Breakdown of academic impact, for papers by Murali Dharan Bashyam Breakdown of academic impact, for papers by Liang Zhu Breakdown of academic impact, for papers by John F. DeCoteau Breakdown of academic impact, for papers by E C Friedberg Breakdown of academic impact, for papers by Alexandra Martins Breakdown of academic impact, for papers by Ronit Aloni-Grinstein
Rankless by CCL
2026